New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT

BACKGROUND: Angiotensin II receptor blockers (ARBs) and angiotensin‐converting enzyme inhibitors (ACEIs) block distinct components of the renin‐angiotensin system. Whether this translates into differential effects on cardiovascular disease events remains unclear. METHODS AND RESULTS: We used the ACC...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Jordan B., Berchie, Ransmond O., Derington, Catherine G., Marcum, Zachary A., Scharfstein, Daniel O., Greene, Tom H., Herrick, Jennifer S., Jacobs, Joshua A., Zheutlin, Alexander R., Bress, Adam P., Cohen, Jordana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547357/
https://www.ncbi.nlm.nih.gov/pubmed/37646208
http://dx.doi.org/10.1161/JAHA.123.030311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547357/
https://www.ncbi.nlm.nih.gov/pubmed/37646208
http://dx.doi.org/10.1161/JAHA.123.030311

Ejemplares similares